Nanoparticle albumin-bound (nab)-paclitaxel is one such chemotherapeutic option, recording the highest ORR (28.6%) when given as a single agent against drug-resistant cervical cancer compared with other chemotherapies (14). Here, ALB is linked to cervical carcinoma.